seminars:datasci:190416
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| seminars:datasci:190416 [2019/04/01 19:47] – qiao | seminars:datasci:190416 [2019/04/05 13:57] (current) – qiao | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | <WRAP centeralign>## | ||
| + | * Date: Tuesday, April 16, 2019 | ||
| + | * Time: 11:45am -- 12:45pm | ||
| + | * Room: WH-G02 (special location) | ||
| + | * Speaker: David Madigan (Columbia University) | ||
| + | * Title: Towards honest inference from real-world healthcare data | ||
| + | |||
| + | <WRAP center box 80%> | ||
| + | <WRAP centeralign> | ||
| + | In practice, our learning healthcare system relies primarily on observational studies generating | ||
| + | one effect estimate at a time using customized study designs with unknown operating | ||
| + | characteristics and publishing – or not – one estimate at a time. When we investigate | ||
| + | the distribution of estimates that this process has produced, we see clear evidence | ||
| + | of its shortcomings, | ||
| + | confidence interval does not include one (i.e. statistically significant effects). | ||
| + | We propose a standardized process for performing observational research that | ||
| + | can be evaluated, calibrated and applied at scale to generate a more reliable and complete | ||
| + | evidence base than previously possible, fostering a truly learning healthcare system. We | ||
| + | demonstrate this new paradigm by generating evidence about all pairwise comparisons of | ||
| + | treatments for depression for a relevant set of health outcomes using four large US insurance | ||
| + | claims databases. In total, we estimate 17,718 hazard ratios, each using a comparative | ||
| + | effectiveness study design and propensity score stratification on par with current state-of-the-art, | ||
| + | albeit one-off, observational studies. Moreover, the process enables us to employ | ||
| + | negative and positive controls to evaluate and calibrate estimates ensuring, for example, | ||
| + | that the 95% confidence interval includes the true effect size approximately 95% of time. | ||
| + | The result set consistently reflects current established knowledge where known, and its | ||
| + | distribution shows no evidence of the faults of the current process. | ||
| + | |||
| + | </ | ||
| + | |||
| + | About the speaker: David Madigan is Professor of Statistics at Columbia University. From 2013 to 2018 he was the Executive Vice-President for Arts and Sciences and Dean of the Faculty of Arts and Sciences at Columbia. He is also a member of the Data Science Initiative at Columbia and part of the OHDSI (the Observational Health Data Sciences and Informatics) program. He received a bachelor' | ||
